• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌胚抗原与糖类抗原19-9在血糖调节异常风险上的协同关联

Synergistic Association of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 on the Risk of Abnormal Glucose Regulation.

作者信息

Cheng Yu-Cheng, Li Yu-Hsuan, Hsu Chiann-Yi, Lee I-Te

机构信息

Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.

Graduate Institute of Data Science, Taipei Medical University, Taipei, Taiwan.

出版信息

Diabetes Metab Syndr Obes. 2020 Jun 10;13:1933-1942. doi: 10.2147/DMSO.S256223. eCollection 2020.

DOI:10.2147/DMSO.S256223
PMID:32606853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7294570/
Abstract

PURPOSE

Carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are tumor-associated antigens. An increased serum level of CEA and CA19-9 separately has been reported in diabetes. In this study, we examined the composite effect of elevated serum levels of both CEA and CA19-9 on subjects with type 2 diabetes and prediabetes.

PATIENTS AND METHODS

A total of 3568 adults who attended a health examination were enrolled into this cross-sectional study. Subjects were grouped into four groups according to the median serum CEA and CA19-9 levels.

RESULTS

Subjects with high CEA and high CA19-9 levels had the highest proportions of diabetes (43.9%) and prediabetes (33.04%). There was a statistically significant trend in the proportion of diabetes across the four groups (P < 0.001). Multivariable logistic regression analysis revealed higher risks of type 2 diabetes in subjects with high CEA and low CA19-9 levels (odds ratio [OR] = 2.10, 95% confidence interval [CI]: 1.39-3.18, P < 0.001) and in those with high CA19-9 and low CEA levels (OR = 2.18, 95% CI: 1.42-3.34, P < 0.001) than in those with low CEA and low CA19-9 levels; among these four groups, the highest risk of type 2 diabetes was observed in subjects with high CEA and high CA19-9 levels (OR = 2.65, 95% CI: 1.81-3.88, P < 0.001). The risk of prediabetes was significantly higher only in subjects with high CEA and high CA19-9 levels compared to those with low CEA and low CA19-9 levels (OR = 1.32, 95% CI: 1.08-1.61, P = 0.006).

CONCLUSION

CEA and CA19-9 had a synergistic ability to increase the risk of type 2 diabetes and prediabetes.

摘要

目的

癌胚抗原(CEA)和糖类抗原19-9(CA19-9)是肿瘤相关抗原。据报道,糖尿病患者中血清CEA和CA19-9水平分别升高。在本研究中,我们检测了血清CEA和CA19-9水平均升高对2型糖尿病和糖尿病前期患者的综合影响。

患者与方法

共有3568名参加健康体检的成年人纳入本横断面研究。根据血清CEA和CA19-9水平中位数将受试者分为四组。

结果

CEA和CA19-9水平均高的受试者中糖尿病(43.9%)和糖尿病前期(33.04%)的比例最高。四组中糖尿病比例存在统计学显著趋势(P<0.001)。多变量逻辑回归分析显示,CEA水平高而CA19-9水平低的受试者(比值比[OR]=2.10,95%置信区间[CI]:1.39-3.18,P<0.001)以及CA19-9水平高而CEA水平低的受试者(OR=2.18,95%CI:1.42-3.34,P<0.001)患2型糖尿病的风险高于CEA和CA19-9水平均低的受试者;在这四组中,CEA和CA19-9水平均高的受试者患2型糖尿病的风险最高(OR=2.65,95%CI:1.81-3.88,P<0.001)。与CEA和CA19-9水平均低的受试者相比,仅CEA和CA19-9水平均高的受试者患糖尿病前期的风险显著更高(OR=1.32,95%CI:1.08-1.61,P=0.006)。

结论

CEA和CA19-9具有协同增加2型糖尿病和糖尿病前期风险的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6414/7294570/97dd9ee0f950/DMSO-13-1933-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6414/7294570/c31809de0187/DMSO-13-1933-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6414/7294570/97dd9ee0f950/DMSO-13-1933-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6414/7294570/c31809de0187/DMSO-13-1933-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6414/7294570/97dd9ee0f950/DMSO-13-1933-g0002.jpg

相似文献

1
Synergistic Association of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 on the Risk of Abnormal Glucose Regulation.癌胚抗原与糖类抗原19-9在血糖调节异常风险上的协同关联
Diabetes Metab Syndr Obes. 2020 Jun 10;13:1933-1942. doi: 10.2147/DMSO.S256223. eCollection 2020.
2
Correlation Between Blood Glucose Control and Levels of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Patients with Type-2 Diabetes Mellitus.2型糖尿病患者血糖控制与糖类抗原19-9及癌胚抗原水平的相关性
Diabetes Metab Syndr Obes. 2022 Aug 15;15:2489-2495. doi: 10.2147/DMSO.S370511. eCollection 2022.
3
[Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].癌胚抗原、甲胎蛋白、糖类抗原125和糖类抗原19-9在胃肠胰神经内分泌肿瘤中的预后价值
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Sep 25;20(9):1002-1008.
4
The value of postoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the early detection of gastric cancer recurrence after curative resection.术后血清癌胚抗原和糖类抗原 19-9 水平对胃癌根治术后早期复发的检测价值。
J Gastric Cancer. 2014 Dec;14(4):221-8. doi: 10.5230/jgc.2014.14.4.221. Epub 2014 Dec 26.
5
Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer.术前癌胚抗原和糖类抗原19-9水平在胃癌中的临床意义
J Clin Gastroenterol. 2001 Jan;32(1):41-4. doi: 10.1097/00004836-200101000-00010.
6
Combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients.血清糖类抗原19-9与癌胚抗原联合检测是胰腺癌患者死亡率的一种简单而准确的预测指标。
Surg Today. 2014 Sep;44(9):1692-701. doi: 10.1007/s00595-013-0752-9. Epub 2013 Oct 9.
7
Association between carcinoembryonic antigen, carbohydrate antigen 19-9 and body mass index in colorectal cancer patients.结直肠癌患者癌胚抗原、糖类抗原19-9与体重指数之间的关联
Mol Clin Oncol. 2013 Sep;1(5):879-886. doi: 10.3892/mco.2013.158. Epub 2013 Jul 23.
8
Dynamic monitoring of carcinoembryonic antigen, CA19-9 and inflammation-based indices in patients with advanced colorectal cancer undergoing chemotherapy.对晚期结直肠癌化疗患者癌胚抗原、CA19-9及炎症相关指标的动态监测
World J Clin Cases. 2022 Jan 21;10(3):899-918. doi: 10.12998/wjcc.v10.i3.899.
9
Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.术前血清癌胚抗原(CEA)、糖类抗原19-9(CA19-9)和糖类抗原242(CA242)联合检测可改善接受手术治疗的结直肠癌患者的预后预测。
Int J Clin Exp Pathol. 2015 Nov 1;8(11):14853-63. eCollection 2015.
10
[The value of NLR, FIB, CEA and CA19-9 in colorectal cancer].[中性粒细胞与淋巴细胞比值、纤维蛋白原、癌胚抗原及糖类抗原19-9在结直肠癌中的价值]
Zhonghua Yu Fang Yi Xue Za Zhi. 2021 Apr 6;55(4):499-505. doi: 10.3760/cma.j.cn112150-20200805-01094.

引用本文的文献

1
Association Between Free Triiodothyronine and Carcinoembryonic Antigen Levels in Type 2 Diabetes Mellitus Patients.2型糖尿病患者游离三碘甲状腺原氨酸与癌胚抗原水平之间的关联
Diabetes Metab Syndr Obes. 2024 Nov 15;17:4267-4275. doi: 10.2147/DMSO.S481433. eCollection 2024.
2
Association of Circulating Carbohydrate Antigen 19-9 Level with Type 2 Diabetic Kidney Disease in Chinese Adults: A Cross-Sectional Study.中国成年人循环中糖类抗原19-9水平与2型糖尿病肾病的关联:一项横断面研究
Diabetes Metab Syndr Obes. 2024 Jan 31;17:467-477. doi: 10.2147/DMSO.S434972. eCollection 2024.
3
High-normal serum carcinoembryonic antigen levels and increased risk of diabetic peripheral neuropathy in type 2 diabetes.

本文引用的文献

1
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.2019年欧洲心脏病学会(ESC)与欧洲糖尿病研究协会(EASD)合作制定的糖尿病、糖尿病前期和心血管疾病指南。
Eur Heart J. 2020 Jan 7;41(2):255-323. doi: 10.1093/eurheartj/ehz486.
2
Trends in prevalence and incidence of diabetes mellitus from 2005 to 2014 in Taiwan.2005 年至 2014 年台湾地区糖尿病患病率和发病率趋势。
J Formos Med Assoc. 2019 Nov;118 Suppl 2:S66-S73. doi: 10.1016/j.jfma.2019.06.016. Epub 2019 Jul 9.
3
HbA1c showed a positive association with carcinoembryonic antigen (CEA) level in only diabetes, not prediabetic or normal individuals.
2型糖尿病患者血清癌胚抗原水平略高于正常范围与糖尿病周围神经病变风险增加
Diabetol Metab Syndr. 2022 Sep 27;14(1):142. doi: 10.1186/s13098-022-00909-7.
4
High Prevalence of Abnormal Carcinoembryonic Antigen in Diabetic Inpatients with Poor Glycemic Control.血糖控制不佳的糖尿病住院患者癌胚抗原异常的高患病率。
Diabetes Metab Syndr Obes. 2022 Aug 4;15:2345-2352. doi: 10.2147/DMSO.S376024. eCollection 2022.
5
The High Prevalence of Short-Term Elevation of Tumor Markers Due to Hyperglycemia in Diabetic Patients.糖尿病患者因高血糖导致肿瘤标志物短期升高的高患病率。
Diabetes Metab Syndr Obes. 2022 Apr 11;15:1113-1122. doi: 10.2147/DMSO.S350599. eCollection 2022.
糖化血红蛋白(HbA1c)仅在糖尿病患者中与癌胚抗原(CEA)水平呈正相关,而在糖尿病前期或正常个体中则无此相关性。
J Clin Lab Anal. 2019 Jul;33(6):e22900. doi: 10.1002/jcla.22900. Epub 2019 Apr 19.
4
Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer, Second Report.日本糖尿病学会(JDS)/日本癌症协会(JCA)糖尿病与癌症联合委员会第二次报告
Diabetol Int. 2016 Mar 7;7(1):12-15. doi: 10.1007/s13340-016-0257-z. eCollection 2016 Mar.
5
2. Classification and Diagnosis of Diabetes: .2. 糖尿病的分类和诊断:
Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28. doi: 10.2337/dc19-S002.
6
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.国际糖尿病联盟(IDF)糖尿病地图集:2017 年全球糖尿病患病率估计数和 2045 年预测值。
Diabetes Res Clin Pract. 2018 Apr;138:271-281. doi: 10.1016/j.diabres.2018.02.023. Epub 2018 Feb 26.
7
HbA1c is Positively Associated with Serum Carcinoembryonic Antigen (CEA) in Patients with Diabetes: A Cross-Sectional Study.糖化血红蛋白(HbA1c)与糖尿病患者血清癌胚抗原(CEA)呈正相关:一项横断面研究。
Diabetes Ther. 2018 Feb;9(1):209-217. doi: 10.1007/s13300-017-0356-2. Epub 2018 Jan 4.
8
The effect of glycemic control on CEA, CA 19-9, amylase and lipase levels.血糖控制对癌胚抗原(CEA)、糖类抗原19-9(CA 19-9)、淀粉酶和脂肪酶水平的影响。
Open Med (Wars). 2014 Sep 17;10(1):8-13. doi: 10.1515/med-2015-0002. eCollection 2015.
9
The serum levels of tumor marker CA19-9, CEA, CA72-4, and NSE in type 2 diabetes without malignancy and the relations to the metabolic control.无恶性肿瘤的2型糖尿病患者血清肿瘤标志物CA19-9、癌胚抗原(CEA)、CA72-4和神经元特异性烯醇化酶(NSE)水平及其与代谢控制的关系。
Saudi Med J. 2017 Feb;38(2):204-208. doi: 10.15537/smj.2017.2.15649.
10
Serum calcium and incident type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study.血清钙与2型糖尿病发病:社区动脉粥样硬化风险(ARIC)研究
Am J Clin Nutr. 2016 Oct;104(4):1023-1029. doi: 10.3945/ajcn.115.130021. Epub 2016 Aug 10.